- US-listed companies
- ENvue Medical, Inc.
- Income statement
ENvue Medical, Inc. (FEED) Income statement
Market cap
$1.47M
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 2 | 3 |
| Revenue growth (%) | - | |||||||||
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 2 |
| Gross margin (%) | ||||||||||
| Research & development | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Operating margin (%) | ||||||||||
| Operating expenses | 2 | 2 | 3 | 4 | 5 | 5 | 6 | 5 | 5 | 5 |
| Operating income | -1 | -2 | -3 | -4 | -5 | -5 | -6 | -5 | -3 | -4 |
| Income before tax | -3 | -3 | -5 | -4 | -6 | -4 | -14 | -5 | -3,682,000 | -3,686,000 |
| Pretax margin (%) | -1,942.9 | -1,185.2 | -2,061.5 | -1,346.2 | -1,096.4 | -692 | -840.7 | -719.8 | -161.3 | -144.1 |
| Provision for income taxes | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Effective tax rate (%) | ||||||||||
| Net income | -3 | -3 | -5 | -4 | -6 | -4 | -14 | -5 | -4 | -4 |
| Net income margin (%) | ||||||||||
| Earnings per share | - | - | - | - | - | - | - | -3.84 | -2.12 | -13.73 |
| Diluted EPS | - | - | - | - | - | - | - | -3.84 | -2.12 | -13.73 |
| EBITDA | - | - | - | - | ||||||
| EBITDA margin (%) | - | - | - | - |